boostAGErx names its compounding pharmacy in a process step rather than a disclaimer, and prices exactly one peptide. That peptide has no product card, and the two products its catalogue does show carry no price at all.
What boostAGErx charges
Sermorelin: $99 — starts at, per month, as a flat rate the seller says covers physician review, clinician visits, the medication and shipping — and does not rise when the dose does
boostAGErx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The priced compound is not the displayed one
Its products page shows two cards, one anti-aging and one weight-loss, and neither carries a figure.
The only price on the page sits in an FAQ answer, and it names a third compound entirely — the growth-hormone-axis peptide the catalogue does not show.
So a reader who scrolls the product grid and stops there sees no price, and a reader who opens the FAQ sees a price for something the grid never offered.
It commits to the price not moving
Its own answer is unambiguous: even if the prescriber raises the dose in later months, the price of the medication and ongoing clinical care stays exactly the same.
It also states what the flat rate covers — the initial physician review, a personalised plan, the online clinician visits and the medication itself, shipped in temperature-controlled packaging.
That scope is why the figure is worth recording despite living in an FAQ: it is a fee for a programme, and the programme is described.
Its catalogue page answers not-found and serves the page anyway
The products page returns a not-found status code while rendering the full document — headings, cards, process steps, FAQ and all.
Any check that reads status codes would file this seller's catalogue as missing, which it plainly is not.
Two deliberately meaningless paths on the same host returned a bare not-found page with none of that content, so the site does distinguish real pages from fake ones — just not through the status code.
What it names and what it does not
It names the compounding pharmacy, its operating company, its clinical entities and a street address, all in its own footer and process copy.
It publishes no state list and makes no coverage claim. What it says about geography is that a clinician licensed in the reader's state will review the intake — a promise about the reviewer, not about where it ships.
No lab work is mentioned as part of any programme, and nothing suggests a panel is covered by the fee.
Who it's for
Buyers who want the dispensing pharmacy named before they pay.
Readers who want a flat rate that does not rise as the dose rises.
Shoppers who want the operating company and its clinical entities named.
Anyone who wants a refund commitment stated in writing if a prescription is declined.
Who should look elsewhere
Readers who want a catalogue with prices on the cards.
Buyers who need to know which states the seller can ship to.
Anyone who wants more than one peptide priced by the same seller.
Shoppers who want lab work included in the programme.
Strengths
Names the compounding pharmacy — Manifest Pharmacy — in a process step, not buried in a disclaimer
Names its operating company, its clinical entities and a street address in its own footer
Commits in writing that the price does not rise when the prescriber raises the dose
Says plainly what happens if a prescription is declined: the membership fee is refunded in full
Trade-offs
Its only published price is for a compound its products page does not list, and the two products it does list carry no price
Its products page answers HTTP 404 while serving the real document, so any status-based check reads the catalogue as missing
Publishes no service-state list and makes no coverage claim at all
The price lives in an FAQ answer rather than on a product card, so a reader who does not open the FAQ never sees a figure
How we verified this
Read the products page in a rendered browser and took the figure from the visible FAQ text, because no card on the page carries one.
Recorded the figure as a starting rate rather than a fixed monthly charge, because the seller's own sentence uses the words starts at.
Quoted the scope of the flat rate from the seller's own answer instead of assuming what a programme fee covers.
Requested two deliberately meaningless paths on this host in the same session and judged presence on the rendered document rather than the status code, because the real catalogue page answers not-found while serving its full content.
Screened both the brand and its named operating company against the live federal warning-letter table, with a known-positive company and a nonsense string as controls in the same run; the one row returned belonged to an unrelated device manufacturer.
A provider to compare boostAGErx against
Auren Rx
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
One. Its products page shows two cards with no prices on them, and the only figure on the site is in an FAQ answer naming a compound that has no card.
Does the price rise if my dose rises?
The seller says no. Its own answer is that the price of the medication and ongoing clinical care remains exactly the same even if the prescriber increases the dose.
Which pharmacy compounds it?
It names one, in the process step describing how the medication is prepared and shipped — not in a disclaimer.
Which states does it serve?
It does not say. It promises a clinician licensed in the reader's state, which describes the reviewer rather than the shipping footprint.
boostAGErx is not a paid partner; this link may earn a commission if that changes. Full disclosure.